[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([OH:8])=O)=[C:4]([S:11]([CH3:14])(=[O:13])=[O:12])[CH:3]=1.[CH2:15]([C:17]1[CH:18]=[C:19]([CH3:29])[C:20]([N:23]2[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]2)=[N:21][CH:22]=1)[CH3:16]>>[Br:1][C:2]1[CH:10]=[CH:9][C:5]([C:6]([N:26]2[CH2:27][CH2:28][N:23]([C:20]3[C:19]([CH3:29])=[CH:18][C:17]([CH2:15][CH3:16])=[CH:22][N:21]=3)[CH2:24][CH2:25]2)=[O:8])=[C:4]([S:11]([CH3:14])(=[O:13])=[O:12])[CH:3]=1Using 4-bromo-2-methanesulfonylbenzoic acid (2.76 g) and 1-(5-ethyl-3-methylpyridin-2-yl)piperazine (1.85 g) described in Preparation Example 81 and by the reaction and treatment in the same manner as in Preparation Example 111, the title compound (3.20 g) was obtained.